1. Home
  2. AMLX vs CASH Comparison

AMLX vs CASH Comparison

Compare AMLX & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$17.61

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$100.12

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMLX
CASH
Founded
2014
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
AMLX
CASH
Price
$17.61
$100.12
Analyst Decision
Strong Buy
Buy
Analyst Count
9
3
Target Price
$20.11
$96.33
AVG Volume (30 Days)
1.2M
172.3K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
0.20%
EPS Growth
65.46
18.88
EPS
N/A
1.57
Revenue
$380,786,000.00
$839,894,000.00
Revenue This Year
N/A
$7.56
Revenue Next Year
N/A
$6.02
P/E Ratio
N/A
$63.33
Revenue Growth
1612.94
11.29
52 Week Low
$4.41
$65.93
52 Week High
$18.61
$101.26

Technical Indicators

Market Signals
Indicator
AMLX
CASH
Relative Strength Index (RSI) 64.35 75.91
Support Level $13.19 $87.19
Resistance Level N/A N/A
Average True Range (ATR) 0.91 2.00
MACD 0.26 0.77
Stochastic Oscillator 83.26 89.79

Price Performance

Historical Comparison
AMLX
CASH

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: